UnknownNot Applicable

Comparison of Bone Morphogenetic Protein-4 (BMP-4) and 7 Levels Between Control and Polycystic Ovarian Syndrome (PCOS) Patients.

Turkey (Türkiye)50 participantsStarted 2010-02

Plain-language summary

The investigators aim to compare the levels of bone morphogenetic protein-4 and -7 (BMP-4 and 7) in blood, follicular fluid and ovarian organ culture supernatant obtained from healthy subjects and polycystic ovarian syndrome (PCOS) patients.

Who can participate

Age range20 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy subjects and PCOS patients at ages 20-35 will be recruited for the study. Exclusion Criteria: * Those with any metabolic or endocrine problems other than PCOS will be excluded from the study.

Trial details

NCT IDNCT01162447

SponsorV.K.V. American Hospital, Istanbul

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2011-02

View on ClinicalTrials.gov More Polycystic Ovarian Syndrome trials